MIT scientists created a new therapy using lipid nanoparticles to reduce neuroinflammation in Alzheimer's, showing potential in early tests on human cells and mice.

UCSD researchers have identified blood biomarkers signaling suicidal thoughts in individuals with depression, potentially impacting mental health treatment.

San Bernardino County won a NACo award for its innovative use of Starlink to bring broadband to regional parks, improving connectivity for visitors and park operations.

UMass Amherst study links household chemical exposure to lower pregnancy chances, with phthalates in items like makeup and vinyl flooring prolonging time to conceive.

An older adult died in a Raynham fire, with officials highlighting the absence of working smoke alarms at the scene. Investigations point to an accidental origin, emphasizing the need for fire safety.

MIT scientists developed a machine-learning model to rapidly predict chemical reaction transition states, a task previously difficult and time-consuming.

MIT researchers' study on deep neural networks shows a strong similarity to human auditory processing, which could improve hearing aids and other auditory devices.

Two women from New York were charged with stealing over 4,600 gift cards from a Braintree pharmacy, believed to be part of a larger scam ring that drains card values quickly.

Houston-based Intuitive Machines aims to land its Nova-C lander on the moon, returning American innovation to the lunar surface and advancing commercial space exploration.

Two Florida university graduates developed DashOne, a wearable sensor system for runners to improve form and prevent injuries, winning $10,000 at a pitch competition.

UC Berkeley engineering professors Ashok Gadgil and Boris Rubinsky were elected as 2023 fellows of the National Academy of Inventors for their contributions to technology and society.

A Texas federal judge has upheld a state ban on TikTok on government devices, against arguments that it infringes on free speech and academic freedom.

A gene-editing trial targeting high cholesterol showed promise, reducing LDL levels by up to 55%, but the safety and long-term effects remain concerns. The trial had a small sample size and did not have a control group.